| Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease M Coskun, M Salem, J Pedersen, OH Nielsen Pharmacol Res. 76, 1-8, 2013 | 347 | 2013 |
| Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals JT Bjerrum, Y Wang, F Hao, M Coskun, C Ludwig, U Günther, OH Nielsen Metabolomics. 11, 122-133, 2015 | 241 | 2015 |
| Intestinal epithelium in inflammatory bowel disease M Coskun Front Med (Lausanne). 1, 24, 2014 | 230 | 2014 |
| Novel targeted therapies for inflammatory bowel disease M Coskun, S Vermeire, OH Nielsen Trends in pharmacological sciences 38 (2), 127-142, 2017 | 180 | 2017 |
| IL-33 is upregulated in colonocytes of ulcerative colitis JB Seidelin, JT Bjerrum, M Coskun, B Widjaya, B Vainer, OH Nielsen Immunolog Lett. 128, 80-85, 2010 | 178 | 2010 |
| Inflammatory pathways of importance for management of inflammatory bowel disease J Pedersen, M Coskun, C Soendergaard, M Salem, OH Nielsen World J Gastroenterol. 20, 64-77, 2014 | 177 | 2014 |
| MAP kinases in inflammatory bowel disease M Coskun, J Olsen, JB Seidelin, OH Nielsen Clin Chim Acta. 412, 513-520, 2011 | 171 | 2011 |
| Intra‐and interreader reproducibility of PI‐RADSv2: A multireader study CP Smith, SA Harmon, T Barrett, LK Bittencourt, YM Law, H Shebel, JY An, ... Journal of Magnetic Resonance Imaging 49 (6), 1694-1703, 2019 | 121 | 2019 |
| Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation J Pedersen, EC LaCasse, JB Seidelin, M Coskun, OH Nielsen Trends Mol Med. 20, 652-665, 2014 | 114 | 2014 |
| MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics. M Coskun, JT Bjerrum, JB Seidelin, OH Nielsen World J Gastroenterol 15 (45), 5751-5753, 2012 | 114 | 2012 |
| MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. M Coskun, JT Bjerrum, JB Seidelin, OH Nielsen World J Gastroenterol 15 (45), 5751-5753, 2012 | 114 | 2012 |
| MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics M Coskun, JT Bjerrum, JB Seidelin, OH Nielsen World J Gastroenterol. 18, 4629-4634, 2012 | 114 | 2012 |
| miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis M Coskun, JT Bjerrum, JB Seidelin, JT Troelsen, J Olsen, OH Nielsen World J Gastroenterol. 19, 4289-4299, 2013 | 113 | 2013 |
| The role of CDX2 in intestinal homeostasis and inflammation M Coskun, JT Troelsen, OH Nielsen Biochim Biophys Acta. 1812, 283-289, 2011 | 108 | 2011 |
| Management of iron-deficiency anemia in inflammatory bowel disease: a systematic review OH Nielsen, M Ainsworth, M Coskun, G Weiss Medicine (Baltimore). 94, e963, 2015 | 102 | 2015 |
| Mechanisms behind efficacy of tnf inhibitors in inflammatory bowel diseases CM Olesen, M Coskun, L Peyrin-Biroulet, OH Nielsen Pharmacol Ther. 159, 110-119, 2016 | 96 | 2016 |
| Grafting studies onto cellulose by atom‐transfer radical polymerization M Coskun, MM Temüz Polymer international 54 (2), 342-347, 2005 | 96 | 2005 |
| Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies M Boyd, M Thodberg, M Vitezic, J Bornholdt, K Vitting-Seerup, Y Chen, ... Nature communications 9 (1), 1661, 2018 | 88 | 2018 |
| Sphingosine-1-phosphate signaling in inflammatory bowel disease OH Nielsen, Y Li, B Johansson-Lindbom, M Coskun Trends in molecular medicine 23 (4), 362-374, 2017 | 68 | 2017 |
| Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells AK Olsen, M Coskun, M Bzorek, MH Kristensen, ET Danielsen, ... Carcinogenesis. 35, 1185-1192, 2013 | 58 | 2013 |
